Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04358237
Title Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (LUPER)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Antonio Calles Blanco
Indications

lung small cell carcinoma

Therapies

Lurbinectedin + Pembrolizumab

Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Gregorio Marañon Recruiting Madrid Spain Details
START - Phase I Unit - HN San Chinarro Recruiting Madrid Spain Details
Start - Unidad Fase I - Fundacion Jimenez Diaz Recruiting Madrid Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field